Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA(TM) - New Innovative Treatment for Irritable Bowel Syndrome with Constipation - GlobeNewswire - Mon Mar 1, 6:04PM CST
GlobeNewswire - CMTX
Mon Mar 1, 6:04PM CST
Knight Therapeutics Inc. (TSX: GUD), ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial availability of IBSRELA (tenapanor), a first-in-class therapy for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Knight has the exclusive right to commercialize IBSRELA in Canada under the terms of a license agreement entered into with Ardelyx, Inc. (NASDAQ: ARDX) in March 2018, which license agreement also provides Knight with exclusive rights to commercialize tenapanor for hyperphosphatemia in Canada. IBSRELA was approved by Health Canada on April 15, 2020 and is now covered by most private insurance companies in Canada.
Knight Announces Filing of Final Base Shelf Prospectus - GlobeNewswire - Wed Dec 23, 5:08PM CST
GlobeNewswire - CMTX
Wed Dec 23, 5:08PM CST
Knight Therapeutics Inc. (TSX: GUD) ("Knight") today has filed and has obtained a receipt for a (final) short form base shelf prospectus (the "Shelf Prospectus"). The Shelf Prospectus was filed with the securities regulatory authorities in each of the provinces of Canada and enables Knight to offer for sale and issue up to $360 million of common shares of Knight ("Common Shares"), subscription receipts of Knight (the "Subscription Receipts") and debt securities of Knight (the "Debt Securities", and collectively with the Common Shares and the Subscription Receipts, the "Securities") from time to time during the 25-month period during which the Shelf Prospectus remains valid. The specific variable terms of any offering of Common Shares, Subscription Receipts or Debt Securities will be set forth in one or more prospectus supplements.
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index - CNW Group - Fri Dec 11, 4:15PM CST
CNW Group - CMTX
Fri Dec 11, 4:15PM CST
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index